Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures
- PMID: 22974002
- PMCID: PMC3482602
- DOI: 10.1186/1471-2377-12-91
Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures
Abstract
Background: The aim of this study was to perform a longitudinal assessment using Quantitative Muscle Testing (QMT) in a cohort of ambulant boys affected by Duchenne muscular dystrophy (DMD) and to correlate the results of QMT with functional measures. This study is to date the most thorough long-term evaluation of QMT in a cohort of DMD patients correlated with other measures, such as the North Star Ambulatory Assessment (NSAA) or three 6-min walk test (6MWT).
Methods: This is a single centre, prospective, non-randomised, study assessing QMT using the Kin Com(®) 125 machine in a study cohort of 28 ambulant DMD boys, aged 5 to 12 years. This cohort was assessed longitudinally over a 12 months period of time with 3 monthly assessments for QMT and with assessment of functional abilities, using the NSAA and the 6MWT at baseline and at 12 months only. QMT was also used in a control group of 13 healthy age-matched boys examined at baseline and at 12 months.
Results: There was an increase in QMT over 12 months in boys below the age of 7.5 years while in boys above the age of 7.5 years, QMT showed a significant decrease. All the average one-year changes were significantly different than those experienced by healthy controls. We also found a good correlation between quantitative tests and the other measures that was more obvious in the stronger children.
Conclusion: Our longitudinal data using QMT in a cohort of DMD patients suggest that this could be used as an additional tool to monitor changes, providing additional information on segmental strength.
Figures



Similar articles
-
Beyond ambulation: Measuring physical activity in youth with Duchenne muscular dystrophy.Neuromuscul Disord. 2020 Apr;30(4):277-282. doi: 10.1016/j.nmd.2020.02.007. Epub 2020 Feb 20. Neuromuscul Disord. 2020. PMID: 32291149 Free PMC article.
-
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.Neurology. 2011 Jul 19;77(3):250-6. doi: 10.1212/WNL.0b013e318225ab2e. Epub 2011 Jul 6. Neurology. 2011. PMID: 21734183
-
Electrical impedance myography in Duchenne muscular dystrophy and healthy controls: A multicenter study of reliability and validity.Muscle Nerve. 2015 Oct;52(4):592-7. doi: 10.1002/mus.24611. Epub 2015 Jul 24. Muscle Nerve. 2015. PMID: 25702806
-
Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy.Disabil Rehabil. 2014;36(22):1918-23. doi: 10.3109/09638288.2014.883444. Epub 2014 Feb 6. Disabil Rehabil. 2014. PMID: 24499260 Free PMC article.
-
Knee Strength and Ankle Range of Motion Impacts on Timed Function Tests in Duchenne Muscular Dystrophy: In the Era of Glucocorticoids.J Neuromuscul Dis. 2022;9(1):147-159. doi: 10.3233/JND-210724. J Neuromuscul Dis. 2022. PMID: 34719507
Cited by
-
Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study.J Neuromuscul Dis. 2020;7(4):407-417. doi: 10.3233/JND-190457. J Neuromuscul Dis. 2020. PMID: 32538860 Free PMC article.
-
Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy.Ann Clin Transl Neurol. 2016 Jun 16;3(8):607-22. doi: 10.1002/acn3.319. eCollection 2016 Aug. Ann Clin Transl Neurol. 2016. PMID: 27606343 Free PMC article.
-
A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene.Neuromuscul Disord. 2018 Sep;28(9):778-786. doi: 10.1016/j.nmd.2018.06.007. Epub 2018 Jun 27. Neuromuscul Disord. 2018. PMID: 30097247 Free PMC article.
-
T2 Mapping and Fat Quantification of Thigh Muscles in Children with Duchenne Muscular Dystrophy.Curr Med Sci. 2019 Feb;39(1):138-145. doi: 10.1007/s11596-019-2012-8. Epub 2019 Mar 13. Curr Med Sci. 2019. PMID: 30868504
-
The Role of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Duchenne Muscular Dystrophy Cardiomyopathy.J Card Fail. 2019 Apr;25(4):259-267. doi: 10.1016/j.cardfail.2019.02.006. Epub 2019 Feb 11. J Card Fail. 2019. PMID: 30763738 Free PMC article.
References
-
- Kakulas BA. Observations on the pathogenesis of duchenne muscular dystrophy in the light of recent progress in molecular genetics. Aust Paediatr J. 1988;24(Suppl 1):4–8. - PubMed